Repaglinide is an anti-diabetic medication used to treat type 2 diabetes. When used along with proper diet and exercise, it helps control blood sugar levels. Repaglinide works by stimulating the pancreas to release insulin, thereby decreasing the amount of glucose in the blood. It is particularly effective for managing postprandial blood sugar spikes and is taken shortly before meals to regulate glucose levels.
Parent: Repaglinide
Parent: Repaglinide Working Standard (Secondary Reference Standard)
Parent: Repaglinide
Parent: Repaglinide
![2-ethoxy-4-(2-((4aS,6S)-6-isobutyl-2,3,4,4a-tetrahydro-1H-pyrido[1,2-a]quinazolin-5(6H)-yl)-2-oxoethyl)benzoic acid](https://veeprho.com/wp-content/uploads/2025/11/2-ethoxy-4-2-4aS6S-6-isobutyl-2344a-tetrahydro-1H-pyrido12-aquinazolin-56H-yl-2-oxoethylbenzoic-acid-2519482-34-7-VE0025904-71d7.png "2-ethoxy-4-(2-((4aS,6S)-6-isobutyl-2,3,4,4a-tetrahydro-1H-pyrido[1,2-a]quinazolin-5(6H)-yl)-2-oxoethyl)benzoic acid")
Parent: Repaglinide
During the production and storage of Repaglinide, related compounds and impurities may form, which must be controlled to ensure the drug’s safety and efficacy. Regulatory authorities, such as the U.S. Food and Drug Administration (FDA), provide guidelines on acceptable impurity levels in Repaglinide formulations.
Key aspects of Repaglinide-related compounds and impurities include:
Advanced analytical techniques, such as High-Performance Liquid Chromatography (HPLC), are used to detect and quantify Repaglinide-related compounds and impurities, ensuring compliance with stringent safety and quality standards.
Repaglinide is an anti-diabetic medication classified as a meglitinide. It helps control blood sugar levels in people with type 2 diabetes by stimulating the pancreas to produce insulin.
No, Repaglinide and Metformin are different types of anti-diabetic medications. Repaglinide stimulates insulin secretion, while Metformin reduces glucose production in the liver and improves insulin sensitivity.
Repaglinide has not been universally discontinued, but its availability may vary by region. It remains a treatment option for type 2 diabetes in many areas.
Yes, potential side effects of Repaglinide include low blood sugar (hypoglycemia), nausea, diarrhea, headache, and weight gain. These side effects are typically mild but require monitoring to ensure proper blood sugar control.
